Vaccination

FDA advisers back Novavax COVID shots as 4th US option

American adults who haven't yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.

Vaccination

FDA panel meets to craft future vaccine strategy

An advisory panel to the U.S. Food and Drug Administration will meet Wednesday to discuss the best way forward with coronavirus vaccines, as evidence grows that variants are eroding the power of the country's current shots.

Vaccination

German panel recommends booster for recipients of 4 vaccines

Germany's independent vaccination advisory panel is recommending a booster shot with a messenger RNA vaccine for people who have had a full course of four Chinese, Indian and Russian COVID-19 vaccines that aren't currently ...

Medications

FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

Medications

FDA skeptical of benefits from experimental ALS drug

Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval.

page 1 from 9